Titre : Thérapie aversive

Thérapie aversive : Questions médicales fréquentes

Termes MeSH sélectionnés :

Data Visualization
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Thérapie aversive : Questions médicales les plus fréquentes", "headline": "Thérapie aversive : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Thérapie aversive : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-24", "dateModified": "2025-02-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Thérapie aversive" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Thérapie comportementale", "url": "https://questionsmedicales.fr/mesh/D001521", "about": { "@type": "MedicalCondition", "name": "Thérapie comportementale", "code": { "@type": "MedicalCode", "code": "D001521", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F04.754.137" } } }, "about": { "@type": "MedicalCondition", "name": "Thérapie aversive", "alternateName": "Aversive Therapy", "code": { "@type": "MedicalCode", "code": "D001348", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Morten Moshagen", "url": "https://questionsmedicales.fr/author/Morten%20Moshagen", "affiliation": { "@type": "Organization", "name": "Ulm University, Albert-Einstein-Allee 47, 89081, Ulm, Germany." } }, { "@type": "Person", "name": "Benjamin E Hilbig", "url": "https://questionsmedicales.fr/author/Benjamin%20E%20Hilbig", "affiliation": { "@type": "Organization", "name": "Department of Psychology, RPTU Kaiserslautern-Landau, Fortstr. 7, 76829, Landau, Germany." } }, { "@type": "Person", "name": "Erich Seifritz", "url": "https://questionsmedicales.fr/author/Erich%20Seifritz", "affiliation": { "@type": "Organization", "name": "Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland." } }, { "@type": "Person", "name": "Adrien T Stanley", "url": "https://questionsmedicales.fr/author/Adrien%20T%20Stanley", "affiliation": { "@type": "Organization", "name": "Departments of Biology and Psychiatry, Columbia University, New York, NY, United States." } }, { "@type": "Person", "name": "David Sulzer", "url": "https://questionsmedicales.fr/author/David%20Sulzer", "affiliation": { "@type": "Organization", "name": "Departments of Psychiatry, Neurology, and Pharmacology, Columbia University Medical Center, New York, NY, United States." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Effectiveness of two visual-pedagogical methods for toothbrushing skills in autistic children: A randomized clinical trial.", "datePublished": "2024-08-12", "url": "https://questionsmedicales.fr/article/39135349", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/scd.13052" } }, { "@type": "ScholarlyArticle", "name": "Hotspots and frontiers of autophagy and chemotherapy in lung cancer: a bibliometric and visualization analysis from 2003 to 2023.", "datePublished": "2024-08-09", "url": "https://questionsmedicales.fr/article/39120721", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00210-024-03354-7" } }, { "@type": "ScholarlyArticle", "name": "Bacteria-responsive functional electrospun membrane: simultaneous on-site visual monitoring and inhibition of bacterial infection.", "datePublished": "2024-08-05", "url": "https://questionsmedicales.fr/article/39101217", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1039/d4tb00963k" } }, { "@type": "ScholarlyArticle", "name": "The development and validation of a novel training infographic for the Physician Visual Analogue Scale (VAS) in Psoriatic Arthritis.", "datePublished": "2024-08-01", "url": "https://questionsmedicales.fr/article/39089827", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3899/jrheum.2024-0152" } }, { "@type": "ScholarlyArticle", "name": "The Spider: a visual, multisystemic symptom impact questionnaire for people with hypermobility-related disorders-validation in adults.", "datePublished": "2024-07-31", "url": "https://questionsmedicales.fr/article/39085705", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10067-024-07071-7" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Disciplines et activités comportementales", "item": "https://questionsmedicales.fr/mesh/D004191" }, { "@type": "ListItem", "position": 3, "name": "Psychothérapie", "item": "https://questionsmedicales.fr/mesh/D011613" }, { "@type": "ListItem", "position": 4, "name": "Thérapie comportementale", "item": "https://questionsmedicales.fr/mesh/D001521" }, { "@type": "ListItem", "position": 5, "name": "Thérapie aversive", "item": "https://questionsmedicales.fr/mesh/D001348" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Thérapie aversive - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Thérapie aversive", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Thérapie aversive", "description": "Comment diagnostiquer un besoin de thérapie aversive ?\nQuels tests sont utilisés pour évaluer les comportements ?\nQui peut prescrire une thérapie aversive ?\nQuels critères sont utilisés pour le diagnostic ?\nLa thérapie aversive est-elle adaptée à tous ?", "url": "https://questionsmedicales.fr/mesh/D001348?mesh_terms=Data+Visualization&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Thérapie aversive", "description": "Quels symptômes indiquent un besoin de thérapie aversive ?\nComment se manifestent les comportements indésirables ?\nLes symptômes varient-ils selon les individus ?\nQuels effets émotionnels peuvent résulter de ces comportements ?\nLes symptômes physiques sont-ils liés à la thérapie aversive ?", "url": "https://questionsmedicales.fr/mesh/D001348?mesh_terms=Data+Visualization&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Thérapie aversive", "description": "Comment prévenir les comportements indésirables ?\nLes interventions précoces sont-elles efficaces ?\nQuel rôle joue le soutien social dans la prévention ?\nLes programmes éducatifs sont-ils utiles ?\nComment la thérapie préventive est-elle mise en œuvre ?", "url": "https://questionsmedicales.fr/mesh/D001348?mesh_terms=Data+Visualization&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Thérapie aversive", "description": "Comment fonctionne la thérapie aversive ?\nQuels types de stimuli sont utilisés ?\nLa thérapie aversive est-elle efficace ?\nCombien de séances sont généralement nécessaires ?\nY a-t-il des alternatives à la thérapie aversive ?", "url": "https://questionsmedicales.fr/mesh/D001348?mesh_terms=Data+Visualization&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Thérapie aversive", "description": "Quelles complications peuvent survenir avec la thérapie aversive ?\nLa thérapie aversive peut-elle aggraver certains symptômes ?\nQuels sont les effets à long terme de cette thérapie ?\nComment gérer les complications éventuelles ?\nLes complications sont-elles fréquentes ?", "url": "https://questionsmedicales.fr/mesh/D001348?mesh_terms=Data+Visualization&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Thérapie aversive", "description": "Quels facteurs augmentent le risque de comportements indésirables ?\nLe stress est-il un facteur de risque ?\nLes troubles mentaux prédisposent-ils à la thérapie aversive ?\nL'isolement social est-il un facteur de risque ?\nLes antécédents de traumatismes influencent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D001348?mesh_terms=Data+Visualization&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un besoin de thérapie aversive ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un professionnel évalue les comportements problématiques et leur impact sur la vie quotidienne." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les comportements ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des questionnaires et des entretiens cliniques sont souvent utilisés pour l'évaluation." } }, { "@type": "Question", "name": "Qui peut prescrire une thérapie aversive ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Un psychologue ou un psychiatre qualifié peut prescrire cette thérapie après évaluation." } }, { "@type": "Question", "name": "Quels critères sont utilisés pour le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les critères incluent la fréquence et l'intensité des comportements indésirables." } }, { "@type": "Question", "name": "La thérapie aversive est-elle adaptée à tous ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, elle n'est pas recommandée pour tous les patients, surtout ceux avec des troubles graves." } }, { "@type": "Question", "name": "Quels symptômes indiquent un besoin de thérapie aversive ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des comportements compulsifs ou des addictions peuvent nécessiter cette thérapie." } }, { "@type": "Question", "name": "Comment se manifestent les comportements indésirables ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent se manifester par des actions répétitives nuisibles ou des dépendances." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon les individus ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de l'individu et de la situation." } }, { "@type": "Question", "name": "Quels effets émotionnels peuvent résulter de ces comportements ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les individus peuvent ressentir de la honte, de l'anxiété ou de la dépression." } }, { "@type": "Question", "name": "Les symptômes physiques sont-ils liés à la thérapie aversive ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes physiques peuvent apparaître en raison du stress lié aux comportements." } }, { "@type": "Question", "name": "Comment prévenir les comportements indésirables ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation et la sensibilisation aux conséquences des comportements peuvent aider à prévenir." } }, { "@type": "Question", "name": "Les interventions précoces sont-elles efficaces ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des interventions précoces peuvent réduire le développement de comportements problématiques." } }, { "@type": "Question", "name": "Quel rôle joue le soutien social dans la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Un bon soutien social peut aider à réduire les comportements indésirables en offrant des alternatives." } }, { "@type": "Question", "name": "Les programmes éducatifs sont-ils utiles ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent sensibiliser aux risques et aux conséquences des comportements indésirables." } }, { "@type": "Question", "name": "Comment la thérapie préventive est-elle mise en œuvre ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut inclure des séances de groupe ou des ateliers sur la gestion des comportements." } }, { "@type": "Question", "name": "Comment fonctionne la thérapie aversive ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elle associe un comportement indésirable à un stimulus désagréable pour réduire ce comportement." } }, { "@type": "Question", "name": "Quels types de stimuli sont utilisés ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des stimuli tels que des sons désagréables ou des sensations physiques peuvent être utilisés." } }, { "@type": "Question", "name": "La thérapie aversive est-elle efficace ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut être efficace pour certains comportements, mais les résultats varient selon les individus." } }, { "@type": "Question", "name": "Combien de séances sont généralement nécessaires ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Le nombre de séances varie, mais plusieurs semaines sont souvent nécessaires pour des résultats." } }, { "@type": "Question", "name": "Y a-t-il des alternatives à la thérapie aversive ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des approches comme la thérapie cognitivo-comportementale peuvent être envisagées." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec la thérapie aversive ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications émotionnelles comme l'anxiété ou la dépression peuvent survenir." } }, { "@type": "Question", "name": "La thérapie aversive peut-elle aggraver certains symptômes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut aggraver des symptômes chez certains patients sensibles ou vulnérables." } }, { "@type": "Question", "name": "Quels sont les effets à long terme de cette thérapie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les effets à long terme peuvent inclure une réduction des comportements, mais aussi des effets négatifs." } }, { "@type": "Question", "name": "Comment gérer les complications éventuelles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi régulier et un ajustement des techniques peuvent aider à gérer les complications." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Elles ne sont pas systématiques, mais peuvent survenir selon la sensibilité du patient." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de comportements indésirables ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents familiaux de troubles mentaux et un environnement stressant peuvent augmenter le risque." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut contribuer au développement de comportements indésirables." } }, { "@type": "Question", "name": "Les troubles mentaux prédisposent-ils à la thérapie aversive ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles mentaux peuvent rendre la thérapie aversive plus nécessaire." } }, { "@type": "Question", "name": "L'isolement social est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'isolement social peut exacerber les comportements indésirables et les addictions." } }, { "@type": "Question", "name": "Les antécédents de traumatismes influencent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traumatismes passés peuvent augmenter la probabilité de comportements problématiques." } } ] } ] }

Sources (10000 au total)

Effectiveness of two visual-pedagogical methods for toothbrushing skills in autistic children: A randomized clinical trial.

This study aimed to compare the effectiveness of two visual pedagogy methods, video modeling and educational posters, on improving tooth-brushing autonomy in 10-12-year-old children with mild autism.... Sixty-four autistic children were randomly assigned to either the video or poster groups using the Rand function in Excel. Toothbrushing skills were divided into five stages: preparation, buccal, occl... After 3 months, there were significant improvements in autonomy scores for both groups, with the video group showing greater benefits (4.37 ± 0.43) compared to the poster group (4.11 ± 0.49) (p = .03)... Both video and poster methods were effective in improving tooth-brushing skills, but video modeling was associated with a higher total autonomy score....

The development and validation of a novel training infographic for the Physician Visual Analogue Scale (VAS) in Psoriatic Arthritis.

Psoriatic arthritis (PsA) is a heterogenous condition with musculoskeletal and skin manifestations. The physician visual analogue scale (VAS) is an important component of many composite scores used in... A novel training infographic was developed with stakeholder involvement, then evaluated in a Latin square design in which 20 patients with PsA were assessed by 10 clinicians. For each group of 10 pati... There was strong agreement between traditional and infographic physician VAS (ICC:0.686, p=0.008). This improved to very strong agreement when incorporated into the 3VAS (ICC:0.989, p<0.001) and 4VAS ... This study has developed and validated a novel training infographic which informs a briefer assessment of the physician global VAS than traditional assessments. This tool has potential applications in...

The Spider: a visual, multisystemic symptom impact questionnaire for people with hypermobility-related disorders-validation in adults.

Hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS) are often accompanied by varied and complex multisystemic comorbid symptoms/conditions. The Spider questionnaire wa... A cross-sectional observational study was conducted over four stages. Three international patient charities aided recruitment of participants through social media and website advertisements. Adults ag... A total of 11,151 participants were recruited across the four stages. Statistically significant, moderate-to-strong correlations were found between all Spider domains and their comparators (p < 0.001,... Convergent and known-group validity of the Spider was established with adults. These results suggest the Spider can measure the presence and impact of multisystemic comorbid symptoms/conditions in adu...

Evaluating a web-based visual acuity and refractive error self-assessment tool in myopic children.

Demands for myopia management are rising. A web-based tool that allows home-performed self-assessments of visual acuity (VA) and refractive error may enable hybrid care pathways and aid in identifying... Myopic children aged ≥6 years old were invited to perform web-based eye tests at home, assisted by a parent. At two myopia control clinics, they also underwent measurements of VA using a Snellen chart... A total of 147 children were enrolled, of whom 116 (51% male; mean age 13 ± 3 years; mean spherical equivalent refraction (SEQ) -5.58 ± 3.05) performed the web-based tests at home. Overall, the home-p... The web-based test for self-assessing vision, performed at home by children with assistance from their parents, yielded VA scores with a precision similar to Snellen chart testing conducted in a clini...

Preparation Regimens to Improve Capsule Endoscopy visualization and diagnostic yield (PrepRICE); a multicentric randomized trial.

Current guidelines recommend bowel preparation before small-bowel capsule endoscopy (SBCE). However, the optimal protocol is yet to be defined. To determine the best timing for preparation in SBCE, we... In this prospective, randomized (1:1:1:1), multicentric study, patients with suspected small bowel bleeding were randomized into four arms: G1 (1L of polyethylene-glycol + ascorbic acid [Moviprep®] th... A total of 387 patients were included; 59% female with a median age of 73 years (IQR 23). The exam completion rate was lower in G1 (90%, p<0.001). Small bowel TT was shorter for patients receiving pur... The group that received the bowel preparation the night before SBCE had poorer outcomes. Intra-procedure purgative regimens reduced SBTT, enhanced visualization, improved DY, and increased angioectasi...

Cryo-Fluorescence Tomography as a Tool for Visualizing Whole-Body Inflammation Using Perfluorocarbon Nanoemulsion Tracers.

We explore the use of intravenously delivered fluorescent perfluorocarbon (PFC) nanoemulsion tracers and multi-spectral cryo-fluorescence tomography (CFT) for whole-body tracer imaging in murine infla... Mixtures of nanoemulsions with different fluorescent emission wavelengths were administered intravenously to naïve mice and models of acute inflammation, colitis, and solid tumor. Mice were euthanized... PFC nanoemulsions were visualized using CFT within tissues of the reticuloendothelial system and inflammatory lesions, consistent with immune cell (macrophage) labeling, as previously reported in in v... CFT is an effective and complementary methodology to in vivo imaging for validating PFC nanoemulsion biodistribution at high spatial localization, bridging the resolution gap between in vivo imaging a...